Nasal cannula vs simple mask vs non-rebreather vs Venturi: choosing the right oxygen delivery device

13 min read By HHZ Editorial Next review

Choosing the right oxygen delivery device is the second decision a prescriber makes after deciding that supplemental oxygen is indicated. The first is how much — flow rate. The second is through what — interface. Each device class has a flow range within which it works as designed, a delivered FiO₂ range, a set of indications where it is the right answer, and a set of scenarios where it is actively wrong. Many bedside errors — a COPD patient retaining CO₂ on a non-rebreather, a hypoxaemic ILD patient under-oxygenated on a nasal cannula at too-low flow, a patient with a simple mask at 3 LPM rebreathing exhaled CO₂ — trace back to a mismatch between the device and the clinical situation.

This article covers the four most common oxygen delivery devices in Indian clinical and home practice — nasal cannula, simple face mask, non-rebreather mask, and Venturi mask — with clear flow ranges, delivered FiO₂ estimates, indications, and the practical considerations that matter for home oxygen patients in the Indian context. The target reader: the respiratory therapist, primary-care physician, emergency medicine trainee, home-care provider, and engaged patient or family caregiver setting up a home oxygen system.

The taxonomy: low-flow, high-flow, fixed-performance

All four devices in this article are either low-flow (patient’s inspiratory effort draws in some room air to supplement the oxygen, so the delivered FiO₂ depends on both the oxygen flow and the patient’s respiratory pattern) or fixed-performance (the device is designed so the delivered FiO₂ is relatively independent of respiratory pattern, within a specified range).

  • Nasal cannula, simple mask, non-rebreather mask: low-flow (variable performance).
  • Venturi mask: fixed-performance (air-entrainment mask).
  • High-flow nasal cannula systems (AIRVO, Vapotherm) are a separate class — covered briefly at the end — with their own fixed-performance profile.

The clinical implication of variable vs fixed performance: in a low-flow device, the patient who breathes rapidly and deeply (high minute ventilation) entrains more room air per breath, diluting the oxygen and lowering the delivered FiO₂. The same flow rate on the same device can deliver different FiO₂ to two patients with different respiratory patterns. The Venturi mask, by contrast, delivers a calibrated FiO₂ regardless of the patient’s breathing pattern (within reason) — which is the entire reason it exists.

Nasal cannula

The workhorse of chronic home oxygen therapy. Two thin plastic prongs sit inside the nares, held in place by tubing that loops over the ears and secures under the chin or behind the head.

Flow range: 1–6 LPM standard; higher flow via conventional nasal cannula causes progressive discomfort (nasal mucosal drying, turbulent flow sensation, gastric distension if swallowed).

Delivered FiO₂: approximately 24% at 1 LPM, 28% at 2 LPM, 32% at 3 LPM, 36% at 4 LPM, 40% at 5 LPM, 44% at 6 LPM. The classic textbook rule-of-thumb: “FiO₂ = 20% + (4 × LPM)” for the standard range. These are estimates assuming normal respiratory pattern and adequate nasal patency; actual delivered FiO₂ may be 4–6 percentage points either way.

Primary indications:

  • Chronic long-term oxygen therapy (COPD, ILD, post-COVID, pediatric BPD)
  • Most ward-based supplemental oxygen for clinically stable patients
  • Post-operative oxygen
  • Oxygen delivery during sleep (far better tolerated than masks)

Contraindications and pitfalls:

  • Obstructed nasal passages — severe nasal septal deviation, nasal polyps, or post-surgical packing. Mouth breathing reduces delivered oxygen meaningfully; a mouth-breathing patient on 2 LPM cannula is probably receiving close to room-air FiO₂.
  • High-flow requirement above 6 LPM — discomfort rises, delivered FiO₂ plateaus because the inspired oxygen is being diluted by mouth-breathing room air; switch devices.
  • Nasal mucosal trauma and bleeding — common with prolonged use in dry climates; humidification at 3+ LPM via bubble humidifier helps.
  • Skin breakdown over the ears and under the nose — pressure injuries from tubing or from the cannula stem against the upper lip in prolonged use; pad with soft gauze, rotate cannula position.
  • Pediatric sizing — adult cannulas do not fit infants or small children; pediatric-specific sizes are required (see pediatric oxygen therapy).

Clinical considerations:

  • Humidification. At flows ≥3 LPM in a dry climate or over several hours, adding a bubble humidifier (filled with distilled or sterile water, attached at the concentrator outlet) reduces nasal dryness and crusting. Change water daily; replace the humidifier bottle per manufacturer instructions.
  • Cleaning and replacement. The Indian humidity environment — particularly in coastal and monsoon-affected regions — accelerates crusting and microbial colonisation of the tubing interior. A reasonable replacement schedule: nasal cannula every 1–2 weeks with daily cleaning (soap and warm water, air-dry); extension tubing every 1–2 months; humidifier bottle weekly disinfection, replace every 2–3 months. In dry high-altitude or arid regions, intervals can extend slightly.
  • Tubing length. Standard cannulas come with 2.1 m (7 ft) tubing; extension tubing adds 4.5 m (15 ft) or more. Home patients benefit from ~12–15 m total length to move around the house. Longer runs (above 20 m) noticeably increase flow resistance and may require a slight flow-setting adjustment to deliver the prescribed oxygen to the patient.

Simple face mask

A disposable plastic mask covering nose and mouth, with side vent holes and a strap over the head. Oxygen tubing connects at the bottom of the mask.

Flow range: minimum 6 LPM, up to 10 LPM. Running a simple mask below 6 LPM is unsafe — the patient rebreathes their own CO₂ trapped in the mask reservoir because the oxygen flow is insufficient to flush it out. Mask at 5 LPM or less: CO₂ accumulation inside the mask is real and can worsen hypercapnia.

Delivered FiO₂: approximately 35% at 6 LPM, 40% at 8 LPM, 50% at 10 LPM. Variable depending on mask fit and respiratory pattern.

Primary indications:

  • Short-term moderate oxygen requirement in acute care (ward patients requiring more than 6 LPM equivalent nasal cannula)
  • Post-anaesthesia recovery
  • Acute exacerbation scenarios where nasal cannula is inadequate and Venturi or non-rebreather is not yet indicated

Contraindications and pitfalls:

  • Low-flow operation (<6 LPM): dangerous due to CO₂ rebreathing.
  • CO₂ retainer patients (severe COPD, obesity hypoventilation): the mask’s relatively uncontrolled FiO₂ of 35–50% is often excessive and can reduce respiratory drive. A Venturi mask is typically preferred for these patients.
  • Chronic home use: uncomfortable for extended wear, makes eating/drinking impractical, impossible for sleep in most patients.
  • Vomiting/reduced consciousness: aspiration risk.
  • Claustrophobia and mask intolerance: common in some patients.

Home use: Simple masks are rarely used for chronic home oxygen; they are largely a hospital device. A patient at home on supplemental oxygen almost always does better on a nasal cannula for comfort and practicality.

Non-rebreather mask (NRB)

A face mask similar in shape to a simple mask but with an attached reservoir bag at the bottom and a set of one-way valves between the bag and the mask body, and sometimes over the side vent holes. On inspiration, oxygen is drawn from the reservoir bag; on exhalation, exhaled air exits through the side vents without entering the bag.

Flow range: 10–15 LPM. The flow must be high enough to keep the reservoir bag inflated throughout inspiration; if the bag collapses during inspiration, the patient is partially drawing in the exhaled gas that is being vented, contaminating the inspired oxygen.

Delivered FiO₂: approximately 60–90%, depending on mask fit and whether both one-way valves are intact. A properly functioning NRB with a well-sealed mask and both valves in place can deliver ~90%; a mask with one valve missing (common on emergency-kit stock masks) or with a loose seal delivers closer to 60%.

Primary indications:

  • Acute severe hypoxaemia in the emergency setting
  • Pre-hospital transport
  • Bridge while a higher-order device (intubation, high-flow nasal cannula, NIV) is being set up
  • Severe CO poisoning (100% oxygen at a high flow rate accelerates COHb clearance)

Contraindications and pitfalls:

  • Chronic use at home: not a chronic device. NRBs are for acute high-FiO₂ need, typically for minutes to hours, not for long-term therapy.
  • CO₂ retainer COPD patients in acute exacerbation: if the patient is clearly hypoxic and an NRB is the only available high-flow device, it is used — but with immediate escalation planning (Venturi mask, NIV, arterial blood gas) because uncontrolled high FiO₂ can worsen hypercapnia in these patients.
  • Valve failure: a missing or damaged one-way valve degrades performance to below a simple mask; emergency-stock NRBs should be checked before use.
  • Claustrophobia: common; the mask plus reservoir bag is visibly confining.
  • Dry upper airway: 10–15 LPM of unhumidified gas is very drying; prolonged use (>1–2 hours) warrants humidification or device escalation.

Home use: Not a home device. An NRB in a home setting is an indicator either of a temporary acute situation (waiting for ambulance, bridging to hospitalisation) or of a clinician who has prescribed inappropriately.

Venturi mask (air-entrainment mask)

A mask with an interchangeable jet adapter at the oxygen inlet. The adapter creates a high-velocity oxygen jet that entrains a calibrated amount of room air through side ports, producing a fixed inspired oxygen fraction. Different colour-coded jet adapters deliver different FiO₂ — 24%, 28%, 31%, 35%, 40%, 50% are the standard options across most manufacturers, each requiring a specified minimum oxygen flow.

Flow range: varies by jet — typically 2–4 LPM for 24% and 28% jets, up to 8–12 LPM for 40% and 50% jets. The specified flow is the minimum flow required for the jet to entrain room air at the designed ratio; higher flows do not change delivered FiO₂ but do increase the total gas flow (useful for tachypnoeic patients).

Delivered FiO₂: precisely the value marked on the jet adapter — 24%, 28%, 31%, 35%, 40%, or 50% — provided the minimum flow is met and the mask fits properly. This is the device’s raison d’être: precise, reproducible FiO₂ independent of the patient’s respiratory pattern.

Primary indications:

  • Acute exacerbation of COPD, particularly in patients at risk of hypercapnic respiratory failure. Venturi 24% or 28% delivers enough supplemental oxygen to correct severe hypoxaemia without risking over-oxygenation and CO₂ rebound.
  • Any clinical scenario requiring a known, titratable FiO₂: post-anaesthesia in a patient with borderline respiratory reserve, tracheostomy-adjacent care, specific ventilation-weaning protocols.

Contraindications and pitfalls:

  • Below-specification flow: if the specified flow is not met, entrainment fails and delivered FiO₂ becomes unpredictable.
  • Mask leak: a poorly sealed mask with room air entering around the seal negates the calibrated entrainment ratio.
  • Patient intolerance: some patients find the jet velocity noisy or uncomfortable.
  • Not a chronic home device: Venturi masks are occasionally used in structured home care for patients with hypercapnic COPD requiring titrated FiO₂ at home, but in Indian home-care practice this is uncommon. More usually, a home CO₂-retainer COPD patient is prescribed a low-flow nasal cannula with specific SpO₂ targets (88–92%) to limit over-oxygenation.

Why Venturi matters for COPD: The British Thoracic Society and ATS/ERS both recommend Venturi 24% or 28% as the initial oxygen delivery device for COPD exacerbation patients in the emergency setting, specifically to avoid the hypercapnia-from-uncontrolled-FiO₂ problem (British Thoracic Society). An Indian emergency medicine trainee should be familiar with this — the reflex of giving “high flow oxygen” via NRB to every dyspnoeic patient is wrong for the CO₂-retainer subgroup.

High-flow nasal cannula (brief mention)

High-flow nasal cannula (HFNC) systems — AIRVO (Fisher & Paykel), Vapotherm, Optiflow — deliver heated, humidified oxygen at flows of 10–60 LPM through specialised nasal cannulas. Delivered FiO₂ is adjustable from 21% to 100%, independently of flow. HFNC provides:

  • Consistent delivered FiO₂ regardless of inspiratory pattern (flow usually exceeds the patient’s peak inspiratory demand)
  • Washout of anatomical dead space, reducing rebreathing
  • Small amount of positive airway pressure (varies with flow, ~1 cmH₂O per 10 LPM flow)
  • Comfortable delivery of very high oxygen flows

HFNC has established roles in hypoxaemic respiratory failure, post-extubation support, and pre-oxygenation for intubation. It is hospital equipment in the Indian context — the machines retail at ₹3,00,000+, consumables are specialised, and the systems are not generally available for home use. A small number of Indian home-care providers offer HFNC rentals for patients in very specific circumstances (post-transplant pulmonary rehabilitation, palliative care for severe ILD) — the setup remains uncommon.

Matching device to scenario: a decision frame

Stable patient, chronic oxygen need, 1–4 LPM: nasal cannula. First choice by large margin.

Stable patient, chronic oxygen need, 5–6 LPM continuous: nasal cannula with humidification. Many ILD patients fit here.

Stable patient, chronic oxygen need, above 6 LPM continuous: consider high-flow nasal cannula if feasible; otherwise, stepped approach with reservoir cannula (for efficiency) or transition to non-invasive ventilation if the problem is ventilatory as well as hypoxaemic.

Acute exacerbation in COPD, in-hospital: Venturi 24% or 28% initially; titrate upward only if SpO₂ targets (88–92%) are not met.

Acute severe hypoxaemia, any cause, in-hospital or pre-hospital: non-rebreather at 15 LPM while preparing escalation (HFNC, NIV, or intubation).

Moderate acute hypoxaemia, short-term, in-hospital: simple mask at 6–10 LPM, or nasal cannula at 4–6 LPM depending on patient comfort.

Chronic home oxygen, pediatric: pediatric-sized nasal cannula with low-flow flow regulator. Masks are very rarely used for chronic pediatric home oxygen.

Device costs and Indian availability

Nasal cannulas are widely available at pharmacies, medical supply shops, and online channels. Adult cannulas retail at ₹30–₹150 depending on tubing length and manufacturer; reusable silicone cannulas cost more but last longer. Pediatric sizes are less widely stocked at retail but available through hospital supply channels.

Simple masks and NRBs retail at ₹50–₹250. Stock quality varies — budget-end masks may have loose-fitting straps or missing one-way valves. For home emergency stock, a named-manufacturer NRB with intact valves is worth confirming before a crisis.

Venturi masks with a set of colour-coded jets retail at ₹500–₹2,000 for a reusable set. Less commonly stocked at retail; typically available through hospital medical supply channels.

Bubble humidifiers for oxygen concentrator outlets retail at ₹150–₹500 for the bottle; disposable prefilled sterile-water versions cost more per use but eliminate water-change hygiene issues.

High-flow nasal cannula systems are hospital equipment; no retail home-care market in India at consumer scale.

For home oxygen patients, see the oxygen concentrator reviews for device-specific guidance on outlet fittings and compatible humidifiers.

Cleaning, hygiene, and replacement in Indian conditions

Indian humidity — particularly during monsoon months in coastal and north-eastern regions — accelerates biofilm formation inside oxygen tubing. A single cannula used for months without replacement becomes a concentrated source of oral and pharyngeal microflora delivered directly to the respiratory tract. A reasonable schedule:

  • Nasal cannula: clean daily with soap and warm water; air-dry; replace every 1–2 weeks with normal use.
  • Extension tubing: wipe external surfaces weekly; replace every 1–3 months.
  • Humidifier bottle: empty and disinfect daily (rinse with vinegar solution or mild bleach, rinse thoroughly); replace the bottle every 2–3 months.
  • Filters on the concentrator (inlet gross filter, inlet fine filter, outlet HEPA if present): follow manufacturer schedule; in dusty Indian conditions, more frequent cleaning is warranted.
  • Masks: disposable masks should be replaced after each clinical use. Reusable silicone masks can be cleaned and re-used per manufacturer instructions; check integrity of valves.

In tropical conditions with high ambient humidity, biofilm formation can be observed as visible discolouration inside the cannula tubing within 2–3 weeks. Any cannula showing visible contamination or any associated respiratory tract infection episode should prompt immediate replacement.

Consult your treating physician or respiratory therapist about the right device for your specific prescription — the flow rate and device selected together determine the actual oxygen delivered, and a mismatch is surprisingly common in home setups.

Closing: device selection is not a detail

The choice of oxygen delivery device is not a minor logistical detail after the flow prescription. It is the second half of the prescription, and getting it wrong produces clinically significant outcomes: under-delivered oxygen in a hypoxaemic ILD patient on the wrong cannula setup, over-delivered oxygen worsening hypercapnia in a COPD retainer on an uncontrolled mask, a pediatric patient mis-sized out of adequate therapy, a chronic home-oxygen user developing infection because cleaning and replacement were never explained. The equipment is cheap; the consequences of picking the wrong piece are not.

A correct prescription specifies both: “3 LPM continuous via nasal cannula, target SpO₂ 90–93%”; or “24% Venturi mask, titrate based on SpO₂ 88–92%, escalate if not met”. A prescription that reads only “oxygen” or “as required” is incomplete and invites downstream errors.

Primary references that inform clinical practice in this area: BTS Oxygen Use in Adults Guideline 2017; ATS/ERS 2020 Home Oxygen Therapy Guideline; AARC Clinical Practice Guideline: Oxygen Therapy in the Acute Care Hospital; manufacturer device-specific instructions for use.